A study of multidrug-resistant organisms in adult intensive care units in Vietnam

Whole-genome sequencing (WGS) to determine multidrug-resistant organisms (MDRO) causing hospital-acquired infection in Vietnam: the Vietnam ICU WGS study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN18160232

Enrollment

400

Registered

2020-02-17

Start date

2017-06-26

Completion date

Unknown

Last updated

2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surveillance of multi-drug resistant organisms, whole-genome sequencing, hospital-acquired infection Infections and Infestations multidrug-resistant organisms, whole-genome sequencing, hospital-acquired infection

Interventions

All patients admitted to the adult intensive care units (ICU) at the National Hospital for Tropical Diseases and Bach Mai hospital were eligible to participate in the study. After giv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged =18 years 2. Admitted to the NHTD ICU and Bach Mai Hospital ICU during the study period 3. Agree to participate in research and sign the consent form

Exclusion criteria

Exclusion criteria: Does not fulfill study inclusion criteria

Design outcomes

Primary

Measure	Time frame
1. Number of patients colonized with MDRO is measured using laboratory analysis of samples taken at baseline, and weekly until discharge 2. Number of patients with clinical evidence of infection with MDRO is measured using laboratory analysis of samples taken at baseline, and weekly until discharge 3. Number of transmission events of MDRO is measured using laboratory analysis of samples taken at baseline, and weekly until discharge	—

Measure

Time frame

1. Number of patients colonized with MDRO is measured using laboratory analysis of samples taken at baseline, and weekly until discharge 2. Number of patients with clinical evidence of infection with MDRO is measured using laboratory analysis of samples taken at baseline, and weekly until discharge 3. Number of transmission events of MDRO is measured using laboratory analysis of samples taken at baseline, and weekly until discharge

—

Secondary

Measure	Time frame
1. Risk factors for colonization/infection with MDRO are measured using patient notes and demographic information and laboratory analysis of samples taken at baseline, and weekly until discharge 2. Outcomes for patients colonized/infected with MDRO is measured using patient notes and laboratory analysis of samples taken at baseline, and weekly until discharge	—

Countries

Viet Nam

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026